Skip to main content

RED DE NANOMEDICINA PARA AVANZAR EN EL DIAGNOSTICO Y EL TRATAMIENTO DE ENFERMEDADES DE ALTO IMPACTO SOCIAL

RED2022-134560-T

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Redes Investigación /Redes Excelencia
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE GRANADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

WorMe: A user-oriented software for Caenorhabditis elegans length determination

  • Llobet Lladó, Josep
  • Garriga Alonso, Núria
  • Muñoz Juan, Amanda
  • Laromaine, Anna
Caenorhabditis elegans is a widely used animal model for biomedicl research. The lenght of this nematode is commonly used to asses its evelopment and its health. Typically, measurements are performed manually; however, software has been developed to automate this process. Most of these tools are designed for stereomicroscope images, and none work reliably for compound microscopy images. Here we present WorMe, a user-friendly software that measures C.elegans length in compound microscopy images. The program is versatile in handling various image types and can be analyse multiple images collectively. Funthermore, the user can accept of discard the detected objects, separate joined worms, correct erroneous measurements, and manually add new worms. The length results are presented in a spreadsheet file, with earch measurement linked to its image. Graphic data can also be exported., The work has been supported partially with RTI2018-096273B-I00, PID2024-1576370B-I00 (BACTIVE), PDC2023-145826-I00 (BIOCCHIP), funded by MCIN/AEI//10.13039/501100011033/FEDER “Una manera de hacer Europa”; the “Severo Ochoa” Programme for Centres of Excellence, in R&D CEX2019-000917-S (FUNFUTURE), CEX2023-001263-S (MATRANS42); the Generalitat de Catalunya (2021SGR00446 Grant), and European Union’s Horizon Europe research and innovation program under grant agreement No 101057527 (NextGEM). AL participates in CSIC-Conexion Nanomedicina del CSIC, EPNOE network, and Red Nanocare 2.0, Grant RED2022-134560-T funded by MCIN/AEI/10.13039/501100011033, JLL acknowledges ayudas JAE ICU, Consejo Superior de Investigaciones Científicas (CSIC), JAEICU-21-ICMAB01 (2021) in the framework of the Master of Bioinformatics and Biostatistics (UOC, 2021), NGA acknowledges ayudas JAEIntro, Consejo Superior de Investigaciones Científicas (CSIC), JAEINT-24-01745, (2024), AMJ acknowledges the Ph.D. scholarship (FPU18/05190)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S). With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Advances in Conductive Nanomaterials for Cardiac Arrhythmia and Future Directions in Bioevaluation Strategies

  • Srinivasan, Sumithra Y.
  • Laromaine, Anna
Cardiac arrhythmia (CA), characterized by irregular heart rhythms, affects nearly 90% of individuals with cardiovascular diseases. Commonly triggered by myocardial infarction (MI) or ion channel dysfunctions, CA is traditionally treated using pacemakers, cardioversion, ablation, and anti-arrhythmic drugs. Recently, emerging strategies like cardiac patches and injectable formulations with conductive nanomaterials (CNMs) have shown promise in restoring cardiac rhythm post-MI. This review explores CNMs-such as gold nanoparticles, carbon nanotubes, and conjugated polymers-that mimic the electrical and mechanical properties of native cardiac tissue. While in vitro studies show encouraging results, translating CNMs to clinical settings faces challenges. Few studies have assessed their safety and efficacy in rodent models, and none in larger animals. This gap stems from the complexity and ethical hurdles of large animal research. To address this, the review advocates using small animal models like zebrafish, Drosophila melanogaster, and Caenorhabditis elegans. These models offer insights into pharmacokinetics, pharmacodynamics, genetic effects, and cardiac parameters such as ejection fraction and cardiac output-data often unattainable in vitro. Such platforms can better evaluate CNMs' safety and efficacy than 2D/3D cultures, accelerating progress toward clinical application., This work was supported by the Spanish Ministry of Science and Innovation (MICINN) through the National Research Agency (AEI) and European Regional Development Funds (ERDF/FEDER), project BIOSOFT-REGE ref PID2021-122645OB-I00, BACTIVE ref PID2024-1576370B-I00, BIOCCHIP ref PDC2023-145826-I00, the Program/Generalitat de Catalunya (2021SGR00446 project), the Severo Ochoa Program of the Spanish Ministry of Science and Innovation (MICINN_Grant CEX2018−000,789-S, CEX2023-001263-S), and the projects FIP-BEAT, and the PDC2022-133755-I00/AEI/10.13039/501100011033 European Union NextGeneration EU/PRTR. This research was also supported by the European Union's Horizon 2020 research and innovation program H2020-MSCA-COFUND-2016 (DOC-FAM, Grant Agreement No. 754397), European Union’s Horizon Europe research and innovation program under grant agreement No 101057527 (NextGEM). Authors participate in the Spanish National Research Council (CSIC) interdisciplinary platform for sustainable plastics toward a circular economy (SusPlast), and in CSIC-Conexion Nanomedicina del CSIC, EPNOE network, and Red Nanocare 2.0, Grant RED2022-134560-T funded by MCIN/AEI/10.13039/501100011033. The authors acknowledge the use of Biorender.com., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Mussel-Inspired Bioadhesive Patch to Selectively Kill Glioblastoma Cells

  • Bolaños-Cardet, Jose
  • Pugliese, Sara
  • Bruna, Jordi
  • Ruiz Molina, Daniel
  • Suárez-García, Salvio
  • Yuste, Víctor J.
Glioblastoma, the most prevalent and aggressive brain tumor, presents significant challenge due to its rapid proliferation, invasive nature, and resistance to conventional therapies. Current treatments, including surgery, radiation, and chemotherapy, frequently lead to recurrence, underscoring the urgent need for innovative solutions. This work develops and evaluates bioinspired adhesive membranes designed as novel strategy to address glioblastoma recurrence post-surgery. Inspired by mussel adhesion, these membranes exhibit strong bioadhesion in wet environments and incorporate various phenolic-based compounds. Among tested combinations, a membrane with catechin demonstrates specific cytotoxic effect on human glioblastoma cells. This effect is investigated through in vitro assays using glioblastoma cell lines, including primary cell cultures. Exposure to this membrane induces changes in cell morphology and internal structures, and alterations in cell adhesion and migration. Additionally, the use of glioblastoma spheroids and ex vivo tissues allow us to mimic glioblastoma microenvironment and assess the membrane efficacy. Reactive oxygen species are suggested to play a main role in the cytotoxic effect, counteracted by the antioxidant N-acetylcysteine. Finally, a comprehensive proteomic study elucidates biological mechanisms underlying the membrane performance. This research highlights the potential of mussel-inspired advanced scaffolds as a localized approach in glioblastoma therapy, suggesting a path for effective anticancer strategies., This work was supported by grant PID2024-161159OB-I00 funded by MICIU/AEI/10.13039/501100011033/ and by ERDF/EU. The ICN2 and IDIBELL are funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, Grant CEX2021-001214-S, funded by MICIU/AEI/10.13039.50110001103. The proteomics analyses were performed in the CRG/UPF Proteomics Unit, which is part of the Spanish National Research Infrastructure ICTS OmicsTech. The authors acknowledge their membership in the NANOCARE 2.0 network (Grant RED2022-134560-T), funded by MICIU/AEI/10.13039.50110001103. We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001214-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Molecular switches meet multivalency: Antimicrobial activity of multimeric peptide assemblies from the pneumococcal LytA autolysin

  • Roig-Molina, Emma
  • Hendrikse, Simone I.S.
  • de Waal, Bas F.M.
  • Nácher-Vázquez, Montserrat
  • Rivas, Luis
  • Meijer E.W.
  • Maestro, Beatriz
  • Sanz, Jesús M.
Peptidic molecular switches are amino acid sequences that alter their conformation in response to external stimuli. One such sequence (P4A, 14 amino acids) is derived from a choline-binding repeat of the LytA autolysin from the respiratory pathogen Streptococcus pneumoniae (pneumococcus) and is directly involved in the recognition of this aminoalcohol by the enzyme. P4A shifts from a native β-hairpin to an amphiphilic α-helix in the presence of detergent micelles or phospholipid vesicles via an unprecedented molecular switching mechanism. Here we explore the application of this structural transition to develop a novel antimicrobial strategy based on the hypothesis of peptides that adopt a defined structure in aqueous solution but switch to an alternative amphiphilic conformation near bacterial membranes, leading to membrane disruption. With this aim we designed and tested linear and dendritic assemblies of P4A as antimicrobial agents against S. pneumoniae. Linear P4A constructs increased pneumococcal membrane permeability to the SYTOX Green fluorescent probe up to 70% at 10 μM, causing premature release of endogenous LytA amidase and inducing autolysis. Moreover, multivalent P4A dendrimers showed markedly stronger bactericidal activity (up to 56,000-fold compared to linear peptides) due to enhanced multivalent interactions. Additionally, a P4A dendrimer was effective in a zebrafish model of antibiotic-resistant pneumococcal infection at a non-toxic, 2.7 nM concentration dose. These results underscore the potential of integrating structural switching and multivalency in next-generation antimicrobial design, Funding sources: Grants PID2022-139209OB-C21, PID2022- 139209OB-C22 and RED2022-134560-T (Nanocare 2.0) funded by MICIU/AEI/10.13039/501100011033 (Spain) and ERDF “A way of making Europe”; Nanomedicine (grant 202180E048) and Antimicrobial Resistance (grant 202590E059) CSIC-HUB networks by Spanish Minis try of Science; CIBER -Consorcio Centro de Investigación Biomédica en Red (CIBERES, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Spain); European Commission Research Executive Agency (Grant Agreement Number: 859752 HEL4CHIR-OLED H2020-MSCA- ITN-2019), the Dutch Research Council (OCENW.M20.256) and the Dutch Ministry of Education, Culture and Science (Gravitation Program 024.005.020)., Peer reviewed, Modelo experimental alternativo-NAM, Organismos alternativos no vertebrados - Microorganismos Unicelulares - Bacterias
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mixed zinc-iron oxide nanoparticles as therapeutic agents against biofilm-associated infections

  • Arroyo-Urea, Eva María
  • Herraiz-Pérez, Aitor
  • Gutiérrez, Lucía
  • Leo, Marta
  • Garmendia, Juncal
  • León, Rafael
  • Quelle-Regaldie, Ana
  • Pensado-López, Alba
  • Luján-Rodríguez, Víctor Manuel
  • Oteo, Marta
  • Morcillo-Alonso, Miguel Ángel
  • Herranz, Fernando
  • González-Paredes, Ana
Bacterial biofilms are a key contributor to antibiotic resistance and therapeutic failure, highlighting the urgent need for alternative treatment strategies. In this study, we investigate the potential of pure iron oxide nanoparticles (IONP) and mixed zinc-iron oxide nanoparticles (Zn-IONP) as nanoplatforms for targeting biofilm-associated infections caused by significant Gram-negative pathogens, specifically Pseudomonas aeruginosa and nontypeable Haemophilus influenzae . Zn-IONP with varying zinc content were synthesized and systematically characterized using DLS, ICP-OES, FTIR, and XRD, confirming the formation of stable, citrate-coated nanoparticles with a maghemite crystalline core. The antibiofilm performance of the nanoparticles was evaluated in vitro . While IONP showed negligible effects, Zn-IONP exhibited a significant, concentration-dependent inhibition of biofilm formation, achieving complete suppression in different strains of nontypeable H . influenzae at the highest concentrations. Importantly, Zn-IONP also demonstrated enhanced efficacy in the eradication of preformed biofilms in this pathogen, indicating their potential for both preventive and therapeutic applications. The toxicity studies revealed an overall acceptable biocompatibility profile, although Zn-IONP displayed moderately increased toxicity, potentially associated with reactive free-radical species generation. To assess in vivo behavior, Zn-IONP were successfully radiolabeled with <sup>68</sup>Ga and tracked using PET/CT imaging, showing predominant accumulation in the liver after intravenous administration. Collectively, these findings highlight the enhanced antibiofilm activity of mixed Zn-IONP and underscore their potential as a promising nanoplatform for the development of alternative therapies targeting biofilm-driven infections., This work was supported by the Attraction of Talent Program of Community of Madrid (Spain) (2019-T1/IND-12906) and Nanomedicine CSIC Hub (Spain) funding (PIE 202180E048). EMAU was recipient of FPU predoctoral grant (Spain) (FPU21/0416). LG and AGP are members of the NANOCARE 2.0 research network (Grant RED2022-134560-T funded by MCIN/AEI/10.13039/501100011033)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Mixed zinc-iron oxide nanoparticles as therapeutic agents against biofilm-associated infections

  • Arroyo-Urea, Eva María
  • Herraiz, Aitor
  • Gutiérrez, Lucía
  • Leo, Marta
  • Garmendia, Junkal
  • León, Rafael
  • Quelle-Regaldie, Ana
  • Pensado-López, Alba
  • Luján-Rodríguez, Víctor Manuel
  • Oteo, Marta
  • Morcillo-Alonso, Miguel Ángel
  • Herranz, Fernando
  • González-Paredes, Ana
Bacterial biofilms are a key contributor to antibiotic resistance and therapeutic failure, highlighting the urgent need for alternative treatment strategies. In this study, we investigate the potential of pure iron oxide nanoparticles (IONP) and mixed zinc-iron oxide nanoparticles (Zn-IONP) as nanoplatforms for targeting biofilm-associated infections caused by significant Gram-negative pathogens, specifically Pseudomonas aeruginosa and nontypeable Haemophilus influenzae. Zn-IONP with varying zinc content were synthesized and systematically characterized using DLS, ICP-OES, FTIR, and XRD, confirming the formation of stable, citrate-coated nanoparticles with a maghemite crystalline core. The antibiofilm performance of the nanoparticles was evaluated in vitro. While IONP showed negligible effects, Zn-IONP exhibited a significant, concentration-dependent inhibition of biofilm formation, achieving complete suppression in different strains of nontypeable H. influenzae at the highest concentrations. Importantly, Zn-IONP also demonstrated enhanced efficacy in the eradication of preformed biofilms in this pathogen, indicating their potential for both preventive and therapeutic applications. The toxicity studies revealed an overall acceptable biocompatibility profile, although Zn-IONP displayed moderately increased toxicity, potentially associated with reactive free-radical species generation. To assess in vivo behavior, Zn-IONP were successfully radiolabeled with 68Ga and tracked using PET/CT imaging, showing predominant accumulation in the liver after intravenous administration. Collectively, these findings highlight the enhanced antibiofilm activity of mixed Zn-IONP and underscore their potential as a promising nanoplatform for the development of alternative therapies targeting biofilm-driven infections.